Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 707,674Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Genotropin

02 3Humatrope

03 3Norditropin

04 4Nutropin

05 5NutropinAq

PharmaCompass

01

Brand Name : Genotropin

Somatropin

arrow
APS Symposium
Not Confirmed

02

Brand Name : NutropinAq

Somatropin (rDNA origin)

arrow
APS Symposium
Not Confirmed

Brand Name : NutropinAq

arrow
APS Symposium
Not Confirmed

Somatropin (rDNA origin)

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2020 Revenue in Millions : 45

2019 Revenue in Millions : 51

Growth (%) : -12

blank

03

Brand Name : Genotropin

Somatropin

arrow
APS Symposium
Not Confirmed

04

Brand Name : NutropinAq

Somatropin (rDNA origin)

arrow
APS Symposium
Not Confirmed

Brand Name : NutropinAq

arrow
APS Symposium
Not Confirmed

Somatropin (rDNA origin)

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2021 Revenue in Millions : 35

2020 Revenue in Millions : 44

Growth (%) : -12

blank

05

Brand Name : Genotropin

Somatropin

arrow
APS Symposium
Not Confirmed

06

Brand Name : NutropinAq

Somatropin (rDNA origin)

arrow
APS Symposium
Not Confirmed

Brand Name : NutropinAq

arrow
APS Symposium
Not Confirmed

Somatropin (rDNA origin)

Main Therapeutic Indication : Rare Diseases

Currency : USD

2022 Revenue in Millions : 29

2021 Revenue in Millions : 35

Growth (%) : -17

blank

07

Brand Name : NutropinAq

Somatropin (rDNA origin)

arrow
APS Symposium
Not Confirmed

Brand Name : NutropinAq

arrow
APS Symposium
Not Confirmed

Somatropin (rDNA origin)

Main Therapeutic Indication : Rare Diseases

Currency : USD

2023 Revenue in Millions : 20

2022 Revenue in Millions : 29

Growth (%) : -31

blank

08

Brand Name : Genotropin

Somatropin

arrow
APS Symposium
Not Confirmed

09

Brand Name : Genotropin

Somatropin

arrow
APS Symposium
Not Confirmed

10

Brand Name : Genotropin

Somatropin

arrow
APS Symposium
Not Confirmed

Brand Name : Genotropin

arrow
APS Symposium
Not Confirmed

Somatropin

Main Therapeutic Indication : Rare Diseases and Disorders

Currency : USD

2024 Revenue in Millions : 470

2023 Revenue in Millions : 539

Growth (%) : -13

blank